Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1474 of 6351
-
A new serum aims to thicken Hair—Will it beat minoxidil?
Disease control OngoingThe purpose of this study is to assess changes in the characteristics of scalp hair among healthy female participants with mild to moderate hair loss, classified as Ludwig Scale I-3 to II-2
Sponsor: Pacagen, Inc. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New nasal spray aims to zap migraines fast
Symptom relief Recruiting nowThe purpose of this study is to learn about the efficacy and safety of PRT-064040 Nasal Spray versus placebo in the acute treatment of moderate or severe migraine.
Phase 2 • Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Can two weeks of intensive therapy tame PTSD?
Symptom relief Recruiting nowThe objective of the study is to obtain knowledge about the treatment of patients who are offered intensive trauma treatment at Nydalen DPS (NDPS) and Søndre Oslo DPS (SODPS). The treatment takes place on an outpatient basis over two weeks. Up to 42 patients will be recruited. Th…
Sponsor: Oslo University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Can red light slow vision loss in dry AMD?
Disease control Not yet recruitingThis prospective, double-blind, randomized controlled trial aims to evaluate the efficacy and safety of repeated low-level red-light (RLRL) therapy in patients with dry age-related macular degeneration (AMD). The primary objective is to assess the effect of RLRL therapy on visual…
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Quercetin: a new hope for lung fibrosis?
Disease control Recruiting nowFibrotic interstitial lung diseases (F-ILDs), including both idiopathic pulmonary fibrosis (IPF) and non-IPF, are chronic and progressive lung diseases characterized by excessive scarring of lung tissue, leading to declining lung function, respiratory failure, and high mortality,…
Sponsor: Katerina M. Antoniou • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New injection plus chemo-radiation targets tough head and neck tumors
Disease control Recruiting nowThis global, open-label, single arm, phase 1b study aims to learn more about whether a treatment called JNJ-90301900 is safe and effective when injected directly into tumors, along with standard chemotherapy and radiation therapy, for participants with head and neck squamous cell…
Phase 1 • Sponsor: Johnson & Johnson Enterprise Innovation Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could a good bacteria on your scalp regrow hair?
Disease control Recruiting nowThis is a single-center, randomized, double-blind, placebo-controlled clinical trial designed to evaluate whether topical application of Lactobacillus reuteri can safely and effectively treat androgenetic alopecia. The study is based on the concept that balancing the scalp's micr…
Phase 2 • Sponsor: Shenzhen People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New combo shows promise for rare blood cancer
Disease control Not yet recruitingThis is a multicenter, randomized, Phase 2 clinical trial designed to evaluate the efficacy and safety of golidocitinib combined with the P-GemOx (pegaspargase + gemcitabine + oxaliplatin) regimen plus PD-1 inhibitor, compared with P-GemOx plus PD-1 inhibitor alone, in participan…
Phase 2 • Sponsor: WEI XU • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Social connection as medicine: a brain-training trial for gaming addiction
Disease control Recruiting nowInternet Gaming Disorder (IGD) involves impaired cognitive control linked to reduced social reward and dACC-DLPFC brain circuit dysfunction. Enhancing social reward may restore this circuit and improve symptoms. This study uses psychological interventions and neuroimaging to expl…
Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could insulin resistance be a hidden driver of heart disease in naples?
Knowledge-focused CompletedThis is an observational retrospective study to verify the prevalence of insulin resistance (IR) in the municipality of Naples and ita association with cardiovascular diseases. Primary outcome measure 1: The prevalence of IR. Primary outcome measure 2: The prevalence of cardiova…
Sponsor: Comune di Napoli • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
AI model could predict prostate cancer spread before surgery
Knowledge-focused Recruiting nowThe pathological-omics and imaging-omics in this study are combined to construct an artificial intelligence (AI) model that can predict whether high-risk prostate cancer patients may have lymph node metastasis. The model determines whether the patient has lymph node metastasis ba…
Sponsor: Anhui Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
MRNA vaccine takes on Hard-to-Treat cancers
Disease control Not yet recruitingCancer-associated fibroblasts (CAFs), as core regulators within the tumor microenvironment, significantly impede the intratumoral penetration of therapeutic agents and suppress the effective infiltration and activation of immune cells by constructing elaborate physical and functi…
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Probiotic LP-LDL® shows promise for diabetes and prediabetes management
Disease control Not yet recruitingThis randomized, double-blind, placebo-controlled clinical trial investigates the effects of the probiotic LP-LDL® (Lactobacillus plantarum ECGC 13110402) on lipid metabolism, glycemic control, inflammatory biomarkers, and cognitive function in adults with prediabetes, type 1 dia…
Sponsor: Aalborg University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo aims to stall aggressive lung cancer
Disease control Not yet recruitingTo evaluate the efficacy and safety of liposome irinotecan combined with platinum and immune checkpoint inhibitor combined with antirotinib maintenance therapy after first-line induction
Phase 2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Which diabetes pill is better for your heart? huge study aims to find out
Disease control OngoingInvestigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Herbal granules may knock out cold symptoms in three days — a rigorous trial puts them to the test
Disease control CompletedThe goal of this clinical trial is to learn if drug Jinhua Qinggan Granules (JHQG) works to treat acute upper respiratory tract infection in adults. It will also learn about the safety of drug JHQG. The main questions it aims to answer is: • Following three days of treatment, th…
Phase 3 • Sponsor: University of Karachi • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a mediterranean diet speed up Post-Surgery bowel recovery?
Knowledge-focused CompletedPostoperative bowel motility is an important indicator of recovery after abdominal surgery and may be influenced by preoperative nutritional status. Adherence to the Mediterranean diet has been associated with favorable gastrointestinal function because of its high content of die…
Sponsor: Bahçeşehir University • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Could a Ketamine-Like drug ease OCD? new trial underway
Symptom relief Recruiting nowThe purpose of this study is to understand how RR-HNK works in the brain to bring about a reduction in OCD symptoms.
Phase 1/2 • Sponsor: Carolyn Rodriguez • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
New drug LB-102 aims to lift bipolar depression
Symptom relief Recruiting nowPhase II study for patients with Bipolar 1 Disorder experiencing major depressive episode. Patient eligible for enrollment will be randomized (like flipping a coin) to either active drug (LB-102 or placebo). Treatment is for 6 weeks.
Phase 2 • Sponsor: LB Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Could a common drug make head and neck cancer treatment more effective?
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of decitabine in combination with standard of care surgery, radiation, and/or chemotherapy and the effectiveness of the combination in treating patients with head and neck squamous cell cancers that are not caused b…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC